Arpan Patel
Pain Medicine · West Des Moines, IANPI 1528453966
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,064 of the $3,119 with a category attached, or 66.2%. Boston Scientific accounts for 79.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $1,630 and has fallen 66.5% since, to $546 in 2025. That places this record below the midpoint for pain medicine clinicians in IA, where the typical reported total is $2,859.
Across 66 payments — averaging $47.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- SPR Therapeutics, Inc$263
- Abbott$108
- Nevro Corp.$85
- Biotronik NRO, Inc.$57
- Medtronic$41
- plus $80 from 4 others
What the payments were for
- Travel & lodging$1,05534%
- Food & beverage$2,06466%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 47 | $2,485 |
| SPR Therapeutics, Inc | 6 | $263 |
| Abbott | 4 | $108 |
| Nevro Corp. | 1 | $85 |
| Biotronik NRO, Inc. | 2 | $57 |
| Medtronic | 2 | $41 |
| Smith+Nephew | 1 | $23 |
| Globus Medical | 1 | $22 |
| Si-bone, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,119 in reported general payments places this provider in the 50th percentile of 31 pain medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 261 | $6,087 |
| Pregabalin | 99 | $2,846 |
| Gabapentin | 109 | $1,184 |
| Baclofen | 52 | $719 |
| Diclofenac Sodium | 79 | $689 |
| Methylprednisolone | 105 | $657 |
| Tramadol Hcl | 79 | $506 |
| Oxycodone Hcl | 31 | $428 |
| Cyclobenzaprine Hcl | 30 | $315 |
| Carbamazepine ErCarbamazepine | 11 | $293 |
| Tizanidine Hcl | 28 | $157 |
| Meloxicam | 50 | $153 |
| Alprazolam | 93 | $51 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in West Des Moines
- Christopher StalveyWest Des Moines$14K
- Jun XuWest Des Moines$4K
- Steven QuamWest Des Moines$1K
- James SykesWest Des Moines$861
- Clay RansdellWest Des Moines$642
- Andrew SpellmanWest Des Moines$304
- Kenneth PollackWest Des Moines$0
- Garry ClarkSioux City$189K
- Jolene SmithClive$85K
- Daniel MoyseDes Moines$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.